Substance Use in the Philippines: Governance, Research & Practice

The Asian Center for Drug Policy (ACDP), in partnership with the National Academy of Science & Technology (NAST), is proud to announce a Call for Papers for its upcoming research & policy forum entitled, “Drug Recovery in the Philippines: Governance, Research and Practice”.

This Call for Papers will give researchers, practitioners, and academicians the opportunity to present their studies, frameworks, and/or policy papers at their upcoming Pre-Conference Webinar series, which will inform the main discussion during the research & policy forum proper.

Please see submission details below:

The Call for Papers is open to:

  • Individuals, groups, organizations, and institutions involved in substance use research, treatment, policy, and/or other related fields
  • Any study in the formats below, provided that the research conducted and data gathered is not dated older than 2015
The following formats are accepted:

  • Systematic reviews of randomized controlled trial
  • Randomized controlled trials
  • Systematic reviews of non-randomized or cohort studies
  • Cohort studies
  • Case control studies
  • Case series
  • Case reports
  • Editorials
  • Informed opinions
  • Expert opinion papers or presentations
  • Best practice frameworks
  • Policy papers

Submissions must fall under the following topics:

The Global and Local Situation on Substance Use: Identifying Key Issues

Deadline of Submission: April 11, 2021
Presentation Date: April 21, 2021

Rules for Submission

Please read the submission rules before submitting an abstract.

  1. Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.
  2. Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit
  3. Presentation Type: Abstracts may be submitted for oral presentation.
  4. The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation
  5. The presenter will present their extended abstract via Zoom on April 21, 2021
  6. Abstracts must be received by the announced deadline.
  7. The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
  8. Abstracts must be submitted in English.
  9. Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.

  • Presenting author’s and co-authors’ (if any) contact details
    • Full first and family name(s)
    • Email address
    • Affiliation details: department, institution / hospital, city, state (if relevant), country
    • Phone number
  • Abstract title – must be in UPPER CASE
  • Abstract textlimited to 1000 words excluding acknowledgements and references. Please note: word count
  • Abstracts can be structured or unstructured (please include references)
    • For Structured abstract, it is recommended to follow this format:
      • Objectives
      • Methods
      • Results
      • Conclusions
      • References
  • Accepted file types are .PDF, .doc, and .docx
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
  • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
  • Submissions may not contain patient/client names, hospital ID numbers or other identifying information.
  • You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.
  • Please contact us (research@acdp.asia, cc: ma.sarahjane.lopez@gmail.com ) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.
  • Please do not submit multiple copies of the same abstract.
Public Health Dimensions of Substance Use

Deadline of Submission: April 10, 2021
Presentation Date: April 28, 2021

Rules for Submission

Please read the submission rules before submitting an abstract.

  1. Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.
  2. Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit
  3. Presentation Type: Abstracts may be submitted for oral presentation.
  4. The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation
  5. The presenter will present their extended abstract via Zoom on April 28, 2021
  6. Abstracts must be received by the announced deadline.
  7. The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
  8. Abstracts must be submitted in English.
  9. Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.

  • Presenting author’s and co-authors’ (if any) contact details
    • Full first and family name(s)
    • Email address
    • Affiliation details: department, institution / hospital, city, state (if relevant), country
    • Phone number
  • Abstract title – must be in UPPER CASE
  • Abstract text – limited to 1000 words excluding acknowledgements and references. Please note: word count
  • Abstracts can be structured or unstructured (please include references)
    • For Structured abstract, it is recommended to follow this format:
      • Objectives
      • Methods
      • Results
      • Conclusions
      • References
  • Accepted file types are .PDF, .doc, and .docx
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
  • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
  • Submissions may not contain patient/client names, hospital ID numbers or other identifying information.
  • You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.
  • Please contact us (research@acdp.asia, cc: ma.sarahjane.lopez@gmail.com ) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.
  • Please do not submit multiple copies of the same abstract.
Support Systems for Persons Who Use Drugs

Deadline of Submission: April 15, 2021
Presentation Date: May 5, 2021

Rules for Submission

Please read the submission rules before submitting an abstract.

  • Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.
  • Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit
  • Presentation Type: Abstracts may be submitted for oral presentation.
  • The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation
  • The presenter will present their extended abstract via Zoom on May 5, 2021
  • Abstracts must be received by the announced deadline.
  • The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
  • Abstracts must be submitted in English.
  • Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.
​Before you begin, please prepare the following information:

  • Presenting author’s and co-authors’ (if any) contact details
    • Full first and family name(s)
    • Email address
    • Affiliation details: department, institution / hospital, city, state (if relevant), country
    • Phone number
  • Abstract title – must be in UPPER CASE
  • Abstract text – limited to 1000 words excluding acknowledgements and references. Please note: word count
  • Abstracts can be structured or unstructured (please include references)
    • For Structured abstract, it is recommended to follow this format:
      • Objectives
      • Methods
      • Results
      • Conclusions
      • References
  • Accepted file types are .PDF, .doc, and .docx
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
  • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
  • Submissions may not contain patient/client names, hospital ID numbers or other identifying information.
  • You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.
  • Please contact us (research@acdp.asia, cc: ma.sarahjane.lopez@gmail.com ) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.
  • Please do not submit multiple copies of the same abstract.
The Science of Substance Use

Deadline of Submission: April 18, 2021
Presentation Date: May 12, 2021

Rules for Submission

Please read the submission rules before submitting an abstract.

    1. Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.
    2. Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit
    3. Presentation Type: Abstracts may be submitted for oral presentation.
    4. The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation
    5. The presenter will present their extended abstract via Zoom on May 12, 2021
    6. Abstracts must be received by the announced deadline.
    7. The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
    8. Abstracts must be submitted in English.
    9. Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.
​Before you begin, please prepare the following information:

    • Presenting author’s and co-authors’ (if any) contact details
      • Full first and family name(s)
      • Email address
      • Affiliation details: department, institution / hospital, city, state (if relevant), country
      • Phone number
    • Abstract title – must be in UPPER CASE
    • Abstract text – limited to 1000 words excluding acknowledgements and references. Please note: word count
    • Abstracts can be structured or unstructured (please include references)
      • For Structured abstract, it is recommended to follow this format:
        • Objectives
        • Methods
        • Results
        • Conclusions
        • References
    • Accepted file types are .PDF, .doc, and .docx
    • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
    • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
    • Submissions may not contain patient/client names, hospital ID numbers or other identifying information.
    • You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.
    • Please contact us (research@acdp.asia, cc: ma.sarahjane.lopez@gmail.com ) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.
    • Please do not submit multiple copies of the same abstract.
Public Health Policy & Interventions

Deadline of Submission: April 20, 2021
Presentation Date: May 19, 2021

Rules for Submission
Please read the submission rules before submitting an abstract.

  • Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.
  • Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit
  • Presentation Type: Abstracts may be submitted for oral presentation.
  • The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation
  • The presenter will present their extended abstract via Zoom on May 19, 2021
  • Abstracts must be received by the announced deadline.
  • The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
  • Abstracts must be submitted in English.
  • Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.
​Before you begin, please prepare the following information:

  • Presenting author’s and co-authors’ (if any) contact details
    • Full first and family name(s)
    • Email address
    • Affiliation details: department, institution / hospital, city, state (if relevant), country
    • Phone number
  • Abstract title – must be in UPPER CASE
  • Abstract text – limited to 1000 words excluding acknowledgements and references. Please note: word count
  • Abstracts can be structured or unstructured (please include references)
    • For Structured abstract, it is recommended to follow this format:
      • Objectives
      • Methods
      • Results
      • Conclusions
      • References
  • Accepted file types are .PDF, .doc, and .docx
  • Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
  • Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
  • Submissions may not contain patient/client names, hospital ID numbers or other identifying information.
  • You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.
  • Please contact us (research@acdp.asia, cc: ma.sarahjane.lopez@gmail.com ) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.
  • Please do not submit multiple copies of the same abstract.